We reported previously that inhibition of FOXM1 dramatically reduced breast cancer proliferation and increased apoptosis [10, 13], effectively blocking the pro-tumorigenic and pro-metastatic actions of FOXM1 [10, 12, 13]. The gene discussed is FOXM1; the disease is breast cancer.